Alert

On August 15, 2023, the U.S. Food and Drug Administration (“FDA”) issued a new guidance document on informed consent (the “Final Guidance”).

The SEC's Insider Trading Case Against a Clinical Trial Physician: Lessons For Physicians, Investors, And Public Companies

Cookie Settings